📛 The Government’s Hidden Cannabis Patent's, Rick Simpson Oil & the War on Natural Medicine
👮 Age Verification Exploit & Content Disclaimer
🔔 IMPORTANT MINISTRY UPDATE & NOTICE OF WEBSITE INTERFERENCE
Dear Readers,
━━━━━━━━━━━━━━━━━━━━
Big Pharma’s Hypocrisy — The Patent, Epidiolex, & Suppressed Plant Medicine
In 2003, the U.S. Department of Health and Human Services secured (Patent US6630507B1), officially recognizing cannabinoids as “antioxidants and neuroprotectants” — beneficial in treating:
Yet under federal law, cannabis remains a Schedule I drug, officially declared as having “no accepted medical use.” This contradiction exposes a policy-driven system prioritizing profits over people — protecting a $50 billion opioid and antidepressant industry.
🌿 The Endocannabinoid System: God’s Thermostat
The endocannabinoid system (ECS), — discovered in the 1990s — is your body’s God-designed biological regulator, balancing:
Cannabinoids from cannabis—THC, CBD, CBG—mimic the body’s natural endocannabinoids, restoring balance (homeostasis) in chronic conditions.
Supporting research:
-
📖 Frontiers in Immunology (2018) — ECS activation reduces inflammation, the root of autoimmune disease.
-
📖 Journal of Neuroimmune Pharmacology (2020) — Cannabinoids protect brain cells, slowing neurodegeneration.
-
📖 Genesis 1:29 — “Every herb bearing seed” was given by God to work with this healing system.
Big Pharma masks symptoms. Cannabis addresses causes.
🩺 Rick Simpson Oil: A Suppressed Natural Remedy
In 2003, Canadian engineer Rick Simpson reported recovery from skin cancer after using a high-THC, full-spectrum cannabis oil inspired by National Cancer Institute research. Known as Rick Simpson Oil (RSO), it’s reportedly helped thousands with:
-
📖 Cancers Journal (2021) — THC and CBD shrink tumors in animal models.
-
Simpson faced legal raids and charges for freely sharing RSO in Canada.
-
U.S. Patent 6630507B1 curiously prioritizes CBD (non-psychoactive) — sidelining THC-based medicines like RSO to favor Big Pharma-backed derivatives like Epidiolex.
But instead of recognition, Rick faced raids, arrests, and charges for distributing medicine freely. Harassed out of Canada, he relocated to Uruguay, the first modern nation to legalize cannabis (2013, under President José Mujica).
Meanwhile, U.S. Patent 6630507B1 downplayed THC and prioritized CBD — paving the way for Big Pharma’s patented drugs like Epidiolex, while sidelining natural cures like RSO.
🔍 Clarification on Language, Evidence & Historical Comparison
The statements and examples presented in this document are grounded in publicly available research, government records, historical rulings, and documented personal experiences. They are not intended to function as medical prescriptions or universal medical claims.
When personal recovery experiences are discussed—including those of Rick Simpson and my own—they are presented as reported outcomes and lived testimony, not as guarantees, diagnoses, or medical advice. Individual results vary, and all medical decisions should involve qualified professionals.
Similarly, references to historical suppression programs such as COINTELPRO are used as contextual and structural comparisons, not as claims that the same program or individuals are operating today. The comparison is intended to highlight recognizable patterns—such as censorship, intimidation, and disruption of lawful advocacy—documented both historically and in modern public records.
This document invites examination, not blind acceptance. All readers are encouraged to review the cited patents, studies, court rulings, and historical records directly.
In 2003, patent No. 6630507b1 was granted to the Department of Health and Human Services. "Cannabinoids have been found to have antioxidant properties." Patent No. 6630507b1 also references 24 other U.S. patents related to cannabis dating back to 1942. U.S. Patent No. 6630507b1 covers the potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases.
📚 The Government Knew All Along
-
1974 National Cancer Institute Study — THC shrank tumors in mice. The study was buried, funding withdrawn.
-
1988 DEA Judge Ruling (Francis Young) — Declared cannabis “one of the safest therapeutically active substances known to man.” Overruled by the Reagan/Bush administration.
-
Modern FOIA Records — Confirm officials knew cannabis was effective, yet kept it illegal.
🧪 Government & Big Pharma Cannabis-Derived Medications (1942–Present)
Despite public claims that cannabis has “no accepted medical use,” at least two dozen cannabinoid-related drugs, isolates, or synthetic analogs have been researched, patented, or commercialized by governments and pharmaceutical corporations since 1942. These products extract, mimic, or isolate compounds found naturally in the cannabis plant — while the whole plant itself remained prohibited.
🔹 Early Government & Military Research (1940s–1970s)
-
Cannabinol (CBN) — studied by U.S. Army and NIH researchers for sedation and pain relief
-
Δ9-THC (isolated) — synthesized and studied following WWII pharmacological programs
-
Δ8-THC — government-researched isomer, later commercialized
-
Nabilone (early synthesis) — cannabinoid analogs explored for nausea
-
Levonantradol — U.S. Army–funded synthetic cannabinoid for pain (1970s)
These compounds were researched while cannabis was simultaneously criminalized.
🔹 FDA-Approved Synthetic & Isolated Cannabinoids (U.S.)
-
Marinol (Dronabinol) — synthetic THC (1985)
-
Syndros (Dronabinol oral solution) — synthetic THC
-
Epidiolex (Cannabidiol) — purified plant-derived CBD
⚠️ None of these are whole-plant medicines.
🔹 Internationally Approved or Government-Backed Cannabinoid Medicines
-
Sativex (Nabiximols) — THC:CBD botanical extract (UK, EU, Canada)
-
Bedrocan Medical Cannabis — standardized government-regulated cannabis (Netherlands)
-
Bediol — THC/CBD pharmaceutical cultivar
-
Tilray Oral Solutions — government-approved medical cannabis extracts
-
Cannador — standardized THC/CBD capsule (Germany)
🔹 Investigational / Suppressed / Abandoned Cannabinoid Drugs
-
Dexanabinol (HU-211) — neuroprotectant studied for stroke & TBI
-
Rimonabant — CB1 antagonist (withdrawn despite metabolic benefits)
-
Ajulemic Acid (CT-3) — synthetic THC metabolite (anti-inflammatory)
-
O-1602 — cannabinoid-like compound targeting inflammation
-
JWH-018 (research compound) — basis for later “synthetic cannabinoids”
-
HU-210 — potent synthetic cannabinoid (Israeli gov’t research)
🔹 Modern Pharma & Government Cannabinoid Programs
-
GW Pharmaceuticals cannabinoid isolates (pre-acquisition by Jazz Pharma)
-
CBG/CBC pharmaceutical isolates currently in development pipelines
📌 The Contradiction Exposed
While dozens of cannabinoid-based drugs have been produced, patented, or approved, the cannabis plant itself remains federally restricted.
-
Whole-plant medicine → illegal
-
Natural extracts → criminalized
-
Pharma derivatives → protected
This contradiction directly conflicts with U.S. Patent 6630507B1, which acknowledges cannabinoids as neuroprotective antioxidants useful in Alzheimer’s, Parkinson’s, stroke, and neurodegenerative disease.
This is not a failure of science; it is a controlled funneling of medicine into patentable form.
🕵️♂️ COINTELPRO 2.0: Modern Suppression of Healing Truth
Between 1956–1971, COINTELPRO was used to infiltrate and silence voices of truth—through surveillance, disinformation, harassment, and sabotage.
Today, we see the same blueprint applied to medical freedom and cannabis advocacy:
-
Content censorship on YouTube, Facebook, and Google
-
Fake “support” emails and phishing attacks targeting this site
-
Digital sabotage of testimony about natural healing and prophecy
-
Lobbying by opioid makers (💰$Millions spent opposing cannabis legalization)
Just as COINTELPRO destroyed civil rights and activist leaders, COINTELPRO 2.0 now targets natural medicine advocates.
🚫 False Alternatives: Delta-8 & Synthetic Cannabinoids
While natural, God-made cannabis remains restricted, synthetic derivatives are promoted:
-
Delta-8 THC (chemically modified, often unsafe)
-
Pharma isolates (patented, expensive, incomplete)
These distractions keep the public from the true, whole-plant medicine God designed while simultaneously classifying it as Schedule I (no accepted medical use) under the Controlled Substances Act.
✝️ My Personal Living Testimony
This isn’t just theory — it’s personal.
I am living proof of the healing power that US6630507B1 describes. Through God’s grace and the natural medicine He provided in creation, I found recovery when pharmaceuticals failed. The very neuroprotective and restorative properties acknowledged in this patent played a role in my healing journey.
The patent proves the truth of what many patients, caregivers, and natural medicine advocates have been saying for decades: cannabis is not a drug of destruction — it is a medicine of restoration.
📜 Biblical Foundation
-
Psalm 104:14 — “He causeth the grass to grow for the cattle, and herb for the service of man.”
-
Genesis 1:29 — “Every herb bearing seed… to you it shall be for meat.”
-
Luke 8:17 — “For nothing is secret, that shall not be made manifest.”
Plant-based cannabinoids, notably CBD and low-dose THC, have been documented in medical literature and clinical trials to provide significant neuroprotective and restorative effects in conditions such as Alzheimer’s disease and addiction recovery, in alignment with established scientific and governmental findings.
Alzheimer’s Disease & Cannabinoid Treatment
Research shows that cannabinoids can help reduce agitation, aggression, and cognitive impairments in Alzheimer’s and dementia patients, with case studies and clinical trials demonstrating symptom improvement and even deprescription of other medications. Cannabinoids have been proven to act as neuroprotectants, limiting neurodegenerative damage by reducing oxidative stress and neuroinflammation—mechanisms central to Alzheimer’s pathology.
-
Multiple studies and clinical observations have shown improvements in cognitive and behavioral symptoms after cannabinoid treatment, some lasting several months or longer.
-
The U.S. patent US6630507B1 specifically affirms cannabinoids’ role as potent neuroprotectants with application in neurodegenerative diseases like Alzheimer’s.
-
Ongoing clinical trials continue to assess the safety, efficacy, and optimal dosing strategies of cannabinoids in Alzheimer’s patients.
Addiction Recovery Using Cannabinoids
CBD has demonstrated substantial, sustained benefits in aiding recovery from substance dependencies, including opioid, cocaine, tobacco, and alcohol addictions.
-
Studies show CBD targets relapse triggers such as anxiety, impaired impulse control, and environmental cues, producing long-lasting reductions in drug-seeking behavior and relapse vulnerability.
-
Evidence supports CBD’s efficacy across multiple substance classes, with results suggesting broader therapeutic utility beyond single-drug addiction.
-
Medical reports detail documented recovery cases, highlighting CBD as a non-addictive, non-psychoactive option for sustained freedom from addiction.
Biblical Perspective: Truth & God’s Creation
Scripturally, God's creation provides natural resources for healing and restoration, often obscured by human systems that may suppress alternative approaches. The documented effectiveness of cannabinoids supports the concept of divine provision embedded in creation, aligning with themes of healing, restoration, and revelation of hidden truths referenced in end-time prophecy.
-
Clinical and governmental acknowledgment of cannabinoids’ healing properties affirms the notion that God’s natural creation holds valuable solutions for human disease and suffering.
U.S. Government Patent Confirmation
U.S. Patent US6630507B1, held by the U.S. government, clearly recognizes cannabinoids as powerful antioxidants and neuroprotectants, beneficial for “limiting damage from oxidative stress and neurodegenerative diseases,” with non-psychoactive cannabinoids preferred for their safety and effectiveness.
In summary, verified medical recoveries from Alzheimer’s disease and addiction through plant-based cannabinoid therapy are documented, providing real-world affirmation of both biblical and scientific truth regarding God’s healing creation.